Design Therapeutics Appoints Justin Gover to Board of Directors
Provided By GlobeNewswire
Last update: Sep 10, 2025
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of industry veteran Justin Gover to its Board of Directors, effective immediately.
Read more at globenewswire.com
